Concepedia

Author

G. Mangold

The University of Texas Health Science Center at San Antonio

Also Known As

G L Mangold, G Mangold, G. L. Mangold, G. Mangold, G.L. Mangold, Gina L. Mangold, Gina Mangold

75

Publications

1.5K

Citations

18

H-Index

29

Concepts

All Affiliations

The University of Texas Health Science Center at San AntonioUniversity of British Columbia
GM

About

G. Mangold is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, pharmacology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

12

736

2

Natural Sciences

2

2

55

3

Biochemistry

1

1

23

4

Biomedical Engineering

1

1

112

5

Biomolecular Engineering

1

1

23

G. Mangold

×

17

Publications

1.3K

Citations

16

H-Index

YearCitations

The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer

Toshio Shimizu, Anthony W. Tolcher, Kyriakos P. Papadopoulos,

Clinical Cancer Research

2012

429

Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel

Xichen Zhang, Helen M. Burt, G. Mangold,

Anti-Cancer Drugs

1997

112

Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S.

John R. MacDonald, Charles C. Muscoplat, Daniel L. Dexter,

PubMed

1997

109

An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel

Xichen Zhang, Helen M. Burt, Daniel D. Von Hoff,

Cancer Chemotherapy and Pharmacology

1997

108

Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.

Kaladhar B. Reddy, G. Mangold, A. Tandon,

PubMed

1992

107

Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase.

Amy S. Morgan, Polly E. Sanderson, Richard F. Borch,

PubMed

1998

78

Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model.

Carolyn D. Britten, Susan G. Hilsenbeck, S. Gail Eckhardt,

PubMed

1999

65

Preclinical Antitumor Activity and Pharmacokinetics of Methyl-2-Benzimidazolecarbamate (FB642)

Desirée Hao, Jinee Rizzo, Stephanie Stringer,

Investigational New Drugs

2002

36

Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment.

Nasreen A. Syed, Jolene J. Windle, Soesiawati R. Darjatmoko,

PubMed

1998

34

Design of New Topoisomerase II Inhibitors Based upon a Quinobenzoxazine Self-Assembly Model

Qingping Zeng, Yan Kwok, Sean M. Kerwin,

Journal of Medicinal Chemistry

1998

32

Page 1